查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2001098

肾臟和泌尿系统医疗设备市场：2026-2032年全球市场预测（按产品、技术、分销管道、应用和最终用户划分）

Nephrology & Urology Devices Market by Product, Technology, Distribution Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，肾臟和泌尿系统医疗设备市场价值将达到 193.6 亿美元，到 2026 年将成长至 215.6 亿美元，到 2032 年将达到 414.2 亿美元，复合年增长率为 11.47%。

主要市场统计数据
基准年 2025 193.6亿美元
预计年份：2026年 215.6亿美元
预测年份 2032 414.2亿美元
复合年增长率 (%) 11.47%

简要概述人口压力、临床需求和技术融合如何重塑肾臟和泌尿系统医疗设备的策略。

受人口结构变化、临床需求和技术融合的驱动，全球肾臟和泌尿系统医疗设备市场正经历快速创新和结构性变革。慢性肾臟病的高发生率持续影响透析的需求，而微创泌尿系统手术的进步正在重新定义肾结石、摄护腺疾病和尿失禁的治疗标准。同时，医疗服务模式向居家护理、门诊手术和数位后续观察的转变，迫使製造商和供应商重新思考产品设计、分销和支援服务。

微创手术、居家照护和数位医疗的融合如何重塑产品设计、照护路径和商业化模式。

由于技术、临床和商业性变革的融合，肾臟和泌尿系统医疗设备领域正经历着一场变革，这些变革正在改变产品的生命週期和治疗路径。微创技术以及雷射和声学疗法的进步提高了手术的精准度并缩短了恢復时间，促使医院和门诊手术中心优先选择能够优化处理能力和提升患者体验的医疗设备。同时，居家透析和携带式血液透析系统的普及催生了新的照护模式，这些模式优先考虑患者的自主性并减轻医疗机构的负担，从而影响着医疗设备在安全性、易用性和远端监测方面的设计。

本研究评估了 2025 年美国关税趋势将如何重塑医疗设备各产品类别的采购、製造地和商业谈判。

预计美国将在2025年采取关税措施并调整贸易政策，促使製造商和供应链相关人员重新评估筹资策略、生产地点和定价方式。关税带来的成本压力可能会增加进口零件和成品的到货成本，进而影响与医院、透析中心和经销商的采购谈判。为此，企业正在探索近岸外包、供应商多元化和加强垂直整合等策略，以保护利润率并维持稳定的供应链。

详细的細項分析突显了推动临床和商业策略的产品、应用、技术、最终用户和通路趋势。

细分市场洞察揭示了不同产品、应用、终端用户、技术和分销管道之间存在的细微需求差异，这些差异都会影响研发重点和市场进入策略。在产品细分方面，导尿管和输尿管支架仍然是需求稳定的基本一次性产品，而内视镜和体外震波碎石设备则在微创治疗逐渐成为标准疗法的领域被优先考虑。透析设备系列尤其值得关注，它涵盖了连续性肾臟替代疗法 (CRRT) 系统、血液透析过滤器、血液透析系统和腹膜透析系统。在血液透析系统方面，家庭环境和医疗机构环境之间存在显着差异，这会影响自动化、安全连锁和远端监控等设备功能。

美洲、欧洲、中东、非洲和亚太地区在监管、还款和基础设施方面的区域差异如何决定部署路径和商业性优先事项。

区域趋势对三大主要地理丛集（美洲、欧洲、中东和非洲以及亚太地区）的普及曲线、监管力度和商业模式均有显着影响。在美洲，成熟的医疗基础设施和不断扩展的居家照护计画推动了居家血液透析的普及和数位化设备的部署，而采购则倾向于优先考虑生命週期成本和已证实的临床疗效。在美洲地区内部，不同司法管辖区在报销模式和医院采购实践方面的差异显而易见，这影响普及的时间和规模。

竞争动态展示了成熟企业、利基创新者和服务主导策略如何塑造产品系列、伙伴关係和市场差异化。

肾臟和泌尿系统医疗设备领域的竞争格局呈现出多元化的态势，既有成熟的医疗设备医疗设备，也有专注于特定治疗方法和数位化改进的新兴企业。市场领导利用其规模优势，投资于整合了资本设备、耗材和远端监测的整合系统，从而与透析中心和医院建立牢固的服务关係。同时，一些专业公司则透过针对性的创新，例如一次性内视镜、先进的体外碎石技术和小型家用透析平台，来应对特定的临床挑战和营运限制，从而实现差异化竞争。

为製造商和供应商提供可操作的策略性倡议，以协调创新、供应链韧性和服务主导的商业化，从而建立可持续的市场优势。

产业领导企业应优先采取一系列切实可行的措施，以确保在快速变化的环境中，临床应用和营运能够保持韧性。首先，透过与临床医生合作设计医疗设备，并融入远端监测功能和使用者友善设计，使研发投资与实际临床工作流程保持一致，从而减轻培训负担。其次，建构灵活的製造和供应商网络，实现跨区域的快速生产分配，以降低关税和地缘政治风险，同时确保产品品质和合规性。

检验我们的发现，该方法结合了临床医生的直接见解、全面的二次研究和严格的数据三角验证。

本分析的调查方法结合了定性研究、有针对性的二手研究以及严格的三角检验，以确保研究结果具有实用性和实证性。一手数据包括对临床医生、医院和透析中心采购经理、技术开发人员以及销售合作伙伴的结构化访谈，旨在收集关于临床需求、推广障碍和服务期望的第一手观点。除这些访谈外，由执业肾臟科医生和泌尿系统组成的顾问小组也对研究结果进行了审查，检验临床有效性和治疗趋势。

本报告总结了肾臟和泌尿系统医疗设备市场成功所需的临床、技术和商业性要求的交集。

总而言之，肾臟和泌尿系统医疗设备市场正处于一个转折点，人口结构变化、临床创新和不断演变的医疗模式相互交织，既带来了机会，也带来了挑战。居家护理和微创手术的普及推动了以患者为中心设计、具备互联性和易于维护的医疗设备的需求成长。同时，商业性成功取决于可验证的疗效、供应链的灵活性以及能够将产品经济效益与更广泛的医疗保健价值目标相契合的经营模式。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：肾臟及泌尿系统医疗设备市场：依产品分类

  • 导管
  • 透析设备
    • 连续性肾臟替代疗法系统
    • 血液透析过滤器
    • 血液透析系统
    • 腹膜透析系统
  • 内视镜
  • 破碎设备
  • 输尿管支架

第九章：肾臟及泌尿系统医疗设备市场：依技术划分

  • 声波技术
  • 电化学技术
  • 雷射技术
  • 超过滤技术

第十章：肾臟和泌尿系统医疗设备市场：按分销管道划分

  • 直销
  • 销售代理
  • 电子商务

第十一章：肾臟和泌尿系统医疗设备市场：按应用领域划分

  • 肾衰竭的治疗
    • CrRt
    • 血液透析
    • 腹膜透析
  • 肾结石清除
    • 体外震波碎石术
    • 雷射碎石术
  • 摄护腺疾病
  • 尿失禁的治疗

第十二章：肾臟与泌尿系统医疗设备市场：依最终用户划分

  • 门诊手术中心
  • 透析中心
  • 居家医疗设施
  • 医院

第十三章：肾臟与泌尿系统医疗设备市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：肾臟及泌尿系统医疗设备市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：肾臟与泌尿系统医疗设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国肾臟及泌尿系统医疗设备市场

第十七章：中国肾臟与泌尿系统医疗设备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast A/S
  • Convatec Group plc
  • Cook Group Incorporated
  • Dornier MedTech
  • Fresenius Medical Care AG & Co. KGaA
  • Hollister Incorporated
  • Medtronic plc
  • Nipro Corporation
  • Olympus Corporation
  • Siemens Healthineers AG
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-F927BA462957

The Nephrology & Urology Devices Market was valued at USD 19.36 billion in 2025 and is projected to grow to USD 21.56 billion in 2026, with a CAGR of 11.47%, reaching USD 41.42 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 19.36 billion
Estimated Year [2026] USD 21.56 billion
Forecast Year [2032] USD 41.42 billion
CAGR (%) 11.47%

A concise orientation to how demographic pressures, clinical demand, and technological convergence are reshaping nephrology and urology device strategies

The global landscape for nephrology and urology devices is undergoing a period of concentrated innovation and structural change driven by demographic pressures, clinical demand, and technological convergence. Chronic kidney disease prevalence continues to shape demand for dialysis modalities while advances in minimally invasive urologic procedures are redefining standards of care for kidney stones, prostate disorders, and urinary incontinence. Meanwhile, the shifting delivery models in healthcare-toward home-based therapies, ambulatory surgical care, and digitally enabled follow-up-are compelling manufacturers and providers to rethink product design, distribution, and support services.

Investors and clinical leaders must consider not only device performance but also lifecycle economics, interoperability with digital platforms, and regulatory pathways that influence product launch timing. As cost containment and value-based procurement intensify, supplier relationships with hospitals, dialysis centers, and home care providers are increasingly framed around bundled services and outcome-based contracting. Consequently, a clear understanding of clinical workflows, patient preferences, and payer dynamics is essential for stakeholders seeking durable differentiation in this sector.

This introduction frames the report's core focus on how evolving clinical needs and technological trajectories intersect with market access, supply chain resilience, and commercialization strategies. It sets the stage for deeper analyses on segmentation, regional dynamics, and the competitive plays that will drive adoption over the coming years.

How convergence of minimally invasive procedures, home-based therapies, and digital health is rewriting product design, care pathways, and commercialization models

The landscape of nephrology and urology devices is being transformed by an overlapping set of technological, clinical, and commercial shifts that are altering product life cycles and care pathways. Minimally invasive technologies and advances in laser and acoustic modalities are increasing procedural precision while reducing recovery times, prompting hospitals and ambulatory surgical centers to prioritize devices that optimize throughput and patient experience. Concurrently, the expansion of home-based dialysis and portable hemodialysis systems is unlocking new models of care that emphasize patient autonomy and reduced facility burden, which in turn influence device design for safety, ease of use, and remote monitoring.

Data-rich devices that integrate sensors and connectivity are enabling predictive maintenance, therapy personalization, and enhanced clinical oversight. Telehealth integration and remote patient monitoring are no longer auxiliary features but core expectations for many end-users seeking continuity of care. This shift to digitally augmented offerings is also changing commercialization strategies: manufacturers that can demonstrate clinical outcomes through real-world data and that provide comprehensive training and service ecosystems gain competitive advantage.

On the commercial front, distribution channels are evolving as direct sales, specialized distributors, and digital marketplaces each play complementary roles. Health systems and payers are increasingly focused on value per episode, driving demand for devices that lower total cost of care while improving outcomes. The intersection of these trends is forcing legacy manufacturers and new entrants alike to accelerate innovation cycles, form strategic partnerships, and re-evaluate pricing and service models to capture long-term adoption.

Assessing how the 2025 United States tariff trajectory will reshape sourcing, manufacturing footprints, and commercial negotiations across device product families

Anticipated tariff measures and trade policy shifts in the United States expected in 2025 are prompting manufacturers and supply-chain stakeholders to reassess sourcing strategies, production footprints, and pricing approaches. Tariff-driven cost pressures are likely to elevate the landed cost of imported components and finished devices, which will ripple through procurement discussions at hospitals, dialysis centers, and distributors. In response, companies are exploring nearshoring, supplier diversification, and increased vertical integration to protect margins and maintain predictable supply.

The cumulative impact will not be uniform across product families. Devices with complex subassemblies or high value-to-weight ratios will experience different economic effects than consumables or high-volume disposables. Procurement teams will intensify scrutiny of total cost of ownership and explore longer-term contracts or alternative sourcing arrangements to mitigate price volatility. At the same time, regulatory and logistical complexity associated with relocating production or qualifying new suppliers may extend lead times and require additional capital investment.

Strategically, firms with flexible manufacturing capabilities and robust quality systems will be better positioned to absorb or offset tariff-induced cost shifts while preserving market access. Collaboration with payers and health systems to align reimbursement models with altered cost structures can ease adoption friction. Moreover, companies that proactively communicate supply-chain risk mitigation and maintain transparent inventory planning will more effectively retain customer confidence during periods of policy-driven disruption.

Detailed segmentation analysis highlighting product, application, technology, end-user, and channel dynamics that determine clinical and commercial strategies

Segmentation insights reveal nuanced demand drivers that vary by product, application, end user, technology, and distribution channel, each influencing R&D focus and go-to-market strategy. Within product segmentation, Catheters and Ureteral Stents continue to be essential disposables with steady demand, while Endoscopes and Lithotripsy Devices are prioritized where minimally invasive interventions are standard practice. The Dialysis Devices group merits particular attention because it includes Continuous Renal Replacement Therapy systems, Hemodiafilters, Hemodialysis Systems, and Peritoneal Dialysis Systems; within Hemodialysis Systems, an important delineation exists between Home Settings and In-Center Settings, which affects device features such as automation, safety interlocks, and telemonitoring.

Application-driven segmentation underscores the clinical pathways that devices must support. Kidney Failure Management spans CRRT, Hemodialysis, and Peritoneal Dialysis, each with distinct clinical workflows and capital-intensity profiles. Kidney Stone Removal differentiates between Extracorporeal Shock Wave Lithotripsy and Laser Lithotripsy, leading to divergent capital equipment and maintenance considerations. Prostate Disorders and Urinary Incontinence Management demand devices that integrate diagnostic precision with therapeutic efficacy and often require coordinated care across urology and continence services.

End-user segmentation further refines market approach: Ambulatory Surgical Centers, Dialysis Centers, Home Care Settings, and Hospitals each present unique procurement processes, staffing models, and clinical priorities, which dictate training, service, and financing requirements. Technology segmentation highlights where innovation is concentrated, including Acoustic Wave Technologies, Electrochemical Technologies, Laser Technologies, and Ultrafiltration Technologies, and these modalities are unevenly distributed across product and application needs. Finally, distribution channel segmentation-comprising Direct Sales, Distributors, and Ecommerce-shapes buyer experience and post-sale support expectations, with digital channels increasing transparency and enabling faster replenishment for consumables.

How regional regulatory, reimbursement, and infrastructure differences across the Americas, Europe Middle East & Africa, and Asia-Pacific determine adoption pathways and commercial priorities

Regional dynamics shape adoption curves, regulatory rigor, and commercial models in meaningful ways across the three major geographic clusters of the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, mature healthcare infrastructure and expanding home-care initiatives are supporting growth in home hemodialysis adoption and digitally enabled device deployment, while procurement tends to emphasize lifecycle cost and proven clinical outcomes. Moving between jurisdictions within the region reveals differences in reimbursement models and hospital purchasing practices that influence timing and scale of adoption.

The Europe, Middle East & Africa complex presents a heterogeneous regulatory and reimbursement environment, where stringent device approvals and localized health technology assessment pathways can lengthen commercialization timelines but also reward demonstrable clinical and cost benefits. In some markets within this region, constrained public budgets push demand toward devices that offer clear efficiency gains or outpatient migration potential. The regulatory focus on patient safety and environmental stewardship also encourages single-use-to-reusable lifecycle evaluations and circular-economy considerations.

Asia-Pacific is characterized by a mix of rapidly modernizing healthcare systems and large, underserved patient populations. Investment in dialysis infrastructure and urology procedural capacity is expanding, and technology adoption is often accelerated by public-private partnerships and government-led initiatives. Manufacturers targeting this region must balance cost-sensitive procurement with the need for robust service networks and culturally tailored patient engagement strategies. Across all regions, localized clinical education, distribution partnerships, and supply-chain resilience are decisive factors for successful market entry and scaling.

Competitive dynamics showing how incumbents, niche innovators, and service-led strategies are shaping product portfolios, partnerships, and market differentiation

Competitive dynamics in nephrology and urology devices reflect a mix of established medtech incumbents, specialized device innovators, and agile emerging firms focused on niche therapies or digital habilitation. Market leaders are leveraging scale to invest in integrated systems that combine capital equipment, consumables, and remote monitoring, thereby creating sticky service relationships with dialysis centers and hospitals. Simultaneously, specialist companies are differentiating through targeted innovations-such as single-use endoscopes, advanced lithotripsy modalities, and compact home dialysis platforms-that address specific clinical pain points and operational constraints.

Strategic activity is concentrated around several themes: consolidation through strategic acquisitions to fill portfolio gaps; partnerships with software and data analytics providers to turn device-generated data into clinical insights; and investment in manufacturing flexibility to support regional production or rapid ramp-up. Supply-chain partnerships and service excellence are increasingly important competitive levers as customers prioritize uptime and predictable consumable supply. New entrants that can demonstrate clinical validation and regulatory readiness may disrupt traditional procurement cycles, but scaling commercial operations and establishing trust with institutional buyers remain significant execution challenges.

Ultimately, companies that combine differentiated clinical performance with comprehensive lifecycle support-training, maintenance, and outcome measurement-are best positioned to capture long-term customer relationships, while nimble innovators can win pockets of rapid adoption by solving specific clinician or patient pain points.

Actionable strategic initiatives for manufacturers and providers to align innovation, supply-chain resilience, and service-led commercialization for durable market advantage

Industry leaders should prioritize a set of actionable initiatives to secure clinical adoption and operational resilience in a rapidly evolving environment. First, align R&D investments with real-world clinical workflows by co-designing devices with clinicians and incorporating remote monitoring and usability features that reduce training burden. Second, build flexible manufacturing and supplier networks that permit rapid allocation of production across regions to mitigate tariff and geopolitical risk while maintaining quality and regulatory compliance.

Third, expand service-oriented business models that bundle capital equipment with consumables, training, and digital monitoring to create differentiated value propositions and recurring revenue streams. Fourth, invest in robust real-world evidence programs and clinical partnerships to generate outcome data that supports reimbursement discussions and procurement decisions. Fifth, tailor go-to-market approaches by end-user segment; for example, prioritize user-friendly home dialysis systems for home care settings and high-throughput, durable devices for in-center use.

Finally, strengthen commercial agility by developing multi-channel distribution strategies that combine direct sales for complex capital equipment with distributor and e-commerce channels for consumables and smaller devices. Cultivate transparent communications with customers about supply-chain mitigation, and design pricing strategies that reflect total cost of care improvements rather than unit price alone. Together, these actions will enhance market responsiveness, reduce adoption friction, and position organizations for sustainable growth.

A robust evidence-based approach combining primary clinician insights, comprehensive secondary research, and rigorous data triangulation to validate findings

The research methodology underpinning this analysis combines primary qualitative engagement, targeted secondary research, and rigorous triangulation to ensure findings are actionable and evidence-based. Primary inputs include structured interviews with clinicians, procurement leaders at hospitals and dialysis centers, technology developers, and distribution partners to capture firsthand perspectives on clinical needs, adoption barriers, and service expectations. These interviews are supplemented by advisory panel reviews with practicing nephrologists and urologists to validate clinical relevance and procedural trends.

Secondary research encompasses a thorough review of peer-reviewed literature, regulatory agency directives, clinical guidelines, and public-domain white papers to establish clinical and technological context. Market intelligence is then synthesized through cross-validation with supplier disclosures, product registrations, and patent landscapes where appropriate. Quantitative and qualitative inputs are triangulated to reduce bias, and key assumptions are stress-tested through scenario analysis focusing on supply-chain disruptions, policy shifts, and technology adoption rates.

Throughout the process, data quality controls include source verification, consistency checks across datasets, and internal peer reviews. Limitations are acknowledged where data granularity is constrained by proprietary information or rapidly evolving policy environments, and recommendations emphasize areas for periodic updates as new evidence emerges.

Concluding synthesis of the intersecting clinical, technological, and commercial imperatives that define success in nephrology and urology device markets

In summation, the nephrology and urology devices landscape is at an inflection point where demographic pressures, clinical innovation, and shifting care models converge to create both opportunity and complexity. The transition toward home-based therapies and minimally invasive interventions increases demand for devices that prioritize patient-centric design, connectivity, and simplified serviceability. At the same time, commercial success will hinge on demonstrable outcomes, supply-chain agility, and business models that align product economics with broader healthcare value objectives.

Stakeholders who invest in flexible manufacturing, strong clinical partnerships, and comprehensive service ecosystems will be better positioned to navigate regulatory variation and policy-driven cost pressures. Strategic segmentation-by product, application, end user, technology, and distribution channel-enables tailored approaches that address specific adoption drivers. Finally, transparent communication around supply mitigation and real-world performance will remain essential to maintaining trust with institutional buyers and patients as the sector modernizes.

These conclusions underscore the importance of an integrated strategy that balances innovation with operational resilience and commercial adaptability to capture the full potential of nephrology and urology device markets.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nephrology & Urology Devices Market, by Product

  • 8.1. Catheters
  • 8.2. Dialysis Devices
    • 8.2.1. CrRt Systems
    • 8.2.2. Hemodiafilters
    • 8.2.3. Hemodialysis Systems
    • 8.2.4. Peritoneal Dialysis Systems
  • 8.3. Endoscopes
  • 8.4. Lithotripsy Devices
  • 8.5. Ureteral Stents

9. Nephrology & Urology Devices Market, by Technology

  • 9.1. Acoustic Wave Technologies
  • 9.2. Electrochemical Technologies
  • 9.3. Laser Technologies
  • 9.4. Ultrafiltration Technologies

10. Nephrology & Urology Devices Market, by Distribution Channel

  • 10.1. Direct Sales
  • 10.2. Distributors
  • 10.3. Ecommerce

11. Nephrology & Urology Devices Market, by Application

  • 11.1. Kidney Failure Management
    • 11.1.1. CrRt
    • 11.1.2. Hemodialysis
    • 11.1.3. Peritoneal Dialysis
  • 11.2. Kidney Stone Removal
    • 11.2.1. Extracorporeal Shock Wave Lithotripsy
    • 11.2.2. Laser Lithotripsy
  • 11.3. Prostate Disorders
  • 11.4. Urinary Incontinence Management

12. Nephrology & Urology Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Dialysis Centers
  • 12.3. Home Care Settings
  • 12.4. Hospitals

13. Nephrology & Urology Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Nephrology & Urology Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Nephrology & Urology Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Nephrology & Urology Devices Market

17. China Nephrology & Urology Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Asahi Kasei Corporation
  • 18.6. B. Braun Melsungen AG
  • 18.7. Baxter International Inc.
  • 18.8. Becton, Dickinson and Company
  • 18.9. Boston Scientific Corporation
  • 18.10. Coloplast A/S
  • 18.11. Convatec Group plc
  • 18.12. Cook Group Incorporated
  • 18.13. Dornier MedTech
  • 18.14. Fresenius Medical Care AG & Co. KGaA
  • 18.15. Hollister Incorporated
  • 18.16. Medtronic plc
  • 18.17. Nipro Corporation
  • 18.18. Olympus Corporation
  • 18.19. Siemens Healthineers AG
  • 18.20. Stryker Corporation
  • 18.21. Teleflex Incorporated
  • 18.22. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 182. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 187. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 188. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 209. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 210. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 214. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 215. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 218. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 219. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 223. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 224. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)